JOSEPHINE VU: Open Payments
NPI 1790256436 · DOWNEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,359 in 114 payments from 25 companies in 2025. Trend: 2023 $2,449 · 2024 $3,424 · 2025 $2,359
Food & beverage: $2,274Education: $85
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $278 |
| Insulet Corporation | 7 | $238 |
| Novo Nordisk Inc | 13 | $224 |
| Mannkind Corporation | 11 | $222 |
| RECORDATI_RARE_DISEASES_INC. | 6 | $191 |
| Neurocrine BioSciences, Inc. | 6 | $176 |
| Amphastar Pharmaceuticals, Inc. | 17 | $141 |
| Lilly USA, LLC | 5 | $118 |
| Tandem Diabetes Care, Inc. | 4 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $81 |
Products named: Omnipod, AFREZZA, ISTURISA, CRENESSITY, TEPEZZA, MOUNJARO, EVENITY, Wegovy.
Industry payments across CA — which companies pay providers there.
